Yet in many organizations, they remain static PowerPoint or Word documents that quickly fall out of sync
As development progresses, teams often maintain multiple versions, duplicate information across documents, and lose traceability between strategic assumptions and supporting evidence.
Rather than serving as the organization's strategic source of truth, the Target Product Profile can gradually become disconnected from the evidence and decisions it was intended to guide.
ATLAS transforms the Target Product Profile from a static planning document into a connected strategic workspace that evolves alongside your product.
Indication and patient population
Dosing and administration
Competitive differentiation
Efficacy and safety profile
Real world evidence
COA strategy
Market access requirements
Among many others
It provides a shared vision that aligns development, medical, and commercial strategy.
Supporting clinical evidence
Value Messages
Evidence generation plans
This ensures that the product strategy remains aligned with the evolving evidence base.
